|
⚲
|
| Keyboard |
| Tighe Reardon | |
|---|---|
| Firm | |
| Address | c/o Aerorx Therapeutics, Inc 11099 North Torrey Pines Rd, Suite 290 La Jolla, CA 92037 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Aerorx Therapeutics Inc | 021-560436 | Executive Officer | 10.4 M of 20.8 M |
||
| Enlaza Therapeutics Inc | 021-557255 | Executive Officer | 15.0 M of 15.0 M |
||
| Enlaza Therapeutics Inc | 021-521146 | Executive Officer | 84.0 M of 110.0 M |
||
| Arialys Therapeutics Inc | 021-466443 | Executive Officer | 14.3 M of 55.0 M |
||
| Enlaza Therapeutics Inc | 021-461697 | Executive Officer | of 0.3 M |
||
| Enlaza Therapeutics Inc | 021-461688 | Executive Officer | |||
| Aristamd Inc | 021-436040 | Executive Officer | 10.3 M of 10.3 M |
||
| Nerio Therapeutics Inc | 021-416368 | Executive Officer | 3.5 M of 10.0 M |
||
| Enlaza Therapeutics Inc | 021-409959 | Executive Officer | |||
| Enlaza Therapeutics Inc | 021-404438 | Executive Officer | |||
| Janux Therapeutics Inc | 021-397786 | Executive Officer | 125.0 M of 125.0 M |
||
| Enlaza Therapeutics Inc | 021-393460 | Executive Officer | 35.3 M of 61.3 M |
||
| Janux Therapeutics Inc | 021-392167 | Executive Officer | 56.0 M of 56.0 M |
||
| Ankasa Regenerative Therapeutics Inc | 021-377785 | Executive Officer | 6.0 M of 12.0 M |
||
| Janux Therapeutics Inc | 021-370889 | Executive Officer | 11.4 M of 15.9 M |
||
| Nerio Therapeutics Inc | 021-370830 | Executive Officer | 3.0 M of 5.8 M |
||
| Aristamd Inc | 021-364067 | Executive Officer | 22.0 M of 22.0 M |
||
| Aristamd Inc | 021-361637 | Executive Officer | 1.0 M of 1.0 M |
||
| Aristamd Inc | 021-350347 | Executive Officer | 1.5 M of 1.5 M |
||
| Aristamd Inc | 021-340533 | Executive Officer | 1.5 M of 1.5 M |
||
| Aristamd Inc | 021-332720 | Executive Officer | 0.5 M of 0.5 M |
||
| Aristamd Inc | 021-328152 | Executive Officer | 1.0 M of 1.0 M |
||
| Aristamd Inc | 021-324380 | Executive Officer | 1.0 M of 1.0 M |
||
| Aristamd Inc | 021-316341 | Executive Officer | 1.0 M of 1.0 M |
||
| Aristamd Inc | 021-308971 | Executive Officer | 2.9 M of 2.9 M |
||
| Aristamd Inc | 021-294917 | Executive Officer | 1.0 M of 1.0 M |
||
| Aristamd Inc | 021-290523 | Executive Officer | 1.0 M of 1.0 M |
||
| Cellular Approaches Inc | 021-274550 | Executive Officer | 2.6 M of 5.1 M |
||
| Synthorx Inc | 021-267863 | Executive Officer | 5.0 M of 10.0 M |
||
| Aristamd Inc | 021-264163 | Executive Officer | 4.6 M of 7.0 M |
||
| Aristamd Inc | 021-259843 | Executive Officer | 1.4 M of 1.4 M |
||
| Aristamd Inc | 021-253057 | Executive Officer | 1.4 M of 1.4 M |
||
| Avalon Ventures Management LLC | |||||
| Avalon BioVentures SPV II LP | 021-465729 | Director | 21.0 M of 21.0 M |
25.3 M | |
| Avalon BioVentures SPV I LP | 021-390393 | Director | 45.0 M of 45.0 M |
||
| Avalon Ventures Xi LP | 021-247446 | Promoter | 116.5 M of 300.0 M |
67.3 M | |
| Avalon BioVentures Management LLC | |||||
| Avalon BioVentures I LP | 021-407387 | Director | of 200.0 M |
127.5 M | |